In Vitro and in Vivo Anti-Inflammatory Effect of a Biotechnologically Modified Borage Seed Extract: Evidence for Lipid Pro-Resolving Mediators’ Implication in the Enhancement of Psoriatic and Atopic Dermatitis Lesions

Abstract

Aim: Resolvins, maresins and lipoxins are lipid mediators issued from essential polyunsaturated fatty acids which are the first anti-inflammatory and pro-resolving signals identified during the resolution phase of inflammation. As borage oil and/or borage seed extracts have shown beneficial action in treatment of atopic dermatitis or eczema in human and canine, we have modified a borage oil component by using biotechnology in order to get a compound structurally related to a polyunsaturated fatty acid, and we have studied its ability to reduce inflammation mediators production through the generation of resolvins, maresins and/or lipoxins. Additionally, we have demonstrated the potent anti-inflammatory effect of this new compound which consists in borage seed oil aminopropanediol amides, through an in vivo study concerning subjects suffering from psoriasis or atopic dermatitis. Study Design/Methods: For the in vitro study, inflammation was induced in co-cultures of human dendritic cells and normal keratinocytes by the addition of PMA and the calcium ionophore A23187. Ability of our borage seed oil aminopropanediol amides to increase resolvin D2, maresin 1 and lipoxins A4 and B4 synthesis was then measured. Pro-inflammatory cytokines (IL-1β, IL-6, IL-8) and PGE2 productions were also quantified. For the in vivo study, 36 subjects suffering from psoriasis or atopic dermatitis have used twice a day during 30 days, a formulation containing borage seed oil aminopropanediol amides. Before the beginning of the study and after 30 days’ treatment, the severity of psoriasis and of atopic dermatitis was evaluated by using the PGA and the SCORAD scoring scales, respectively. Results: Borage seed oil aminopropanediol amides were able to significantly increase the resolvin D2, maresin 1 and lipoxins A4 and B4 synthesis. Concomitantly, they were also able to significantly inhibit the production of IL-1β, IL-6, IL-8 and PGE2 induced by the PMA and the calcium ionophore A23187 in the in vitro co-culture model used. Introduced in formulation, borage seed oil aminopropanediol amides significantly reduced the clinical manifestations of psoriasis and atopic dermatitis. Conclusion: Our in vitro and in vivo study clearly showed the anti-inflammatory activity of borage seed oil aminopropanediol amides and emphasized the putative role of pro-resolving lipid mediators in the treatment of atopic dermatitis, psoriasis or other inflammation-induced skin diseases.

Share and Cite:

Chene, G. , Baillif, V. , Goethem, E. , Branka, J. , Ionescu, T. , Robert, G. and Lefeuvre, L. (2015) In Vitro and in Vivo Anti-Inflammatory Effect of a Biotechnologically Modified Borage Seed Extract: Evidence for Lipid Pro-Resolving Mediators’ Implication in the Enhancement of Psoriatic and Atopic Dermatitis Lesions. Journal of Cosmetics, Dermatological Sciences and Applications, 5, 151-160. doi: 10.4236/jcdsa.2015.52018.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Serhan, C.N. (2014) Pro-Resolving Lipid Mediators Are Leads for Resolution Physiology. Nature, 510, 92-101.
http://dx.doi.org/10.1038/nature13479
[2] Masoodi, M., Kuda, O., Rossmeisl, M., Flachs, P. and Kopecky, J. (2015) Lipid Signaling in Adipose Tissue: Connecting Inflammation & Metabolism. Biochimica et Biophysica Acta, 1851, 503-518.
http://dx.doi.org/10.1016/j.bbalip.2014.09.023
[3] Ono, E., Dutile, S., Kazani, S., Wechsler, M.E., Yang, J., Hammock, B.D., Douda, D.N., Tabet, Y., Khaddaj-Mallat, R., Sirois, M., Sirois, C., Rizcallah, E., Rousseau, E., Martin, R., Sutherland, E.R., Castro, M., Jarjour, N.N., Israel, E. and Levy, B.D. (2014) Lipoxin Generation Is Related to Soluble Epoxide Hydrolase Activity in Severe Asthma. American Journal of Respiratory and Critical Care Medicine, 190, 886-897.
http://dx.doi.org/10.1164/rccm.201403-0544OC
[4] Giudetti, A.M. and Cagnazzo, R. (2012) Beneficial Effects of n-3 PUFA on Chronic Airway Inflammatory Diseases. Prostaglandins Other Lipid Mediators, 99, 57-67.
http://dx.doi.org/10.1016/j.prostaglandins.2012.09.006
[5] Hsiao, H.M., Sapinoro, R.E., Thatcher, T.H., Croasdell, A., Levy, E.P., Fulton, R.A., Olsen, K.C., Pollock, S.J., Serhan, C.N., Phipps, R.P. and Sime, P.J. (2013) A Novel Anti-Inflammatory and Pro-Resolving Role for Resolvin D1 in Acute Cigarette Smoke-Induced Lung Inflammation. PLoS ONE, 8, e58258.
http://dx.doi.org/10.1371/journal.pone.0058258
[6] Uddin, M. and Levy, B.D. (2011) Resolvins: Natural Agonists for Resolution of Pulmonary Inflammation. Progress in Lipid Research, 50, 75-88.
http://dx.doi.org/10.1016/j.plipres.2010.09.002
[7] Kennedy, A., Fearon, U., Veale, D.J. and Godson, C. (2011) Macrophages in Synovial Inflammation. Frontiers in Immunology, 2, 52.
http://dx.doi.org/10.3389/fimmu.2011.00052
[8] Janakiram, N.B. and Rao, C.V. (2009) Role of Lipoxins and Resolvins as Anti-Inflammatory and Proresolving Mediators in Colon Cancer. Current Molecular Medicine, 9, 565-571.
http://dx.doi.org/10.2174/156652409788488748
[9] Saevik, B.K., Bergvall, K., Holm, B.R., Saijonmaa-Koulumies, L.E., Hedhammar, A., Larsen, S. and Kristensen, F. (2004) A Randomized, Controlled Study to Evaluate the Steroid Sparing Effect of Essential Fatty Acid Supplementation in the Treatment of Canine Atopic Dermatitis. Veterinary Dermatology, 15, 137-145.
http://dx.doi.org/10.1111/j.1365-3164.2004.00378.x
[10] Bahmer, F.A. and Schafer, J. (1992) Treatment of Atopic Dermatitis with Borage Seed Oil (Glandol)—A Time Series Analytic Study. Kinderarztliche Praxis, 60, 199-202.
[11] Lopes, C., Silva, D., Delgado, L., Correia, O. and Moreira, A. (2013) Functional Textiles for Atopic Dermatitis: A Systematic Review and Meta-Analysis. Pediatric Allergy and Immunology, 24, 603-613.
http://dx.doi.org/10.1111/pai.12111
[12] Kanehara, S., Ohtani, T., Uede, K. and Furukawa, F. (2007) Undershirts Coated with Borage Oil Alleviate the Symptoms of Atopic Dermatitis in Children. European Journal of Dermatology, 17, 448-449.
[13] Foster, R.H., Hardy, G. and Alany, R.G. (2009) Borage Oil in the Treatment of Atopic Dermatitis. Nutrition, 26, 708-718.
http://dx.doi.org/10.1016/j.nut.2009.10.014
[14] Bamford, J.T., Ray, S., Musekiwa, A., van Gool, C., Humphreys, R. and Ernst, E. (2013) Oral Evening Primrose Oil and Borage Oil for Eczema. Cochrane Database of Systematic Reviews, 4, Article ID: CD004416.
http://dx.doi.org/10.1002/14651858.cd004416.pub2
[15] Bath-Hextall, F.J., Jenkinson, C., Humphreys, R. and Williams, H.C. (2012) Dietary Supplements for Established Atopic Eczema. Cochrane Database of Systematic Reviews, 2, Article ID: CD005205.
http://dx.doi.org/10.1002/14651858.cd005205.pub3
[16] Rahman, M., Beg, S., Ahmad, M.Z., Kazmi, I., Ahmed, A., Rahman, Z., Ahmad, F.J. and Akhter, S. (2013) Omega-3 Fatty Acids as Pharmacotherapeutics in Psoriasis: Current Status and Scope of Nanomedicine in Its Effective Delivery. Current Drug Targets, 14, 708-722.
http://dx.doi.org/10.2174/1389450111314060011
[17] Brosche, T. and Platt, D. (2000) Effect of Borage Oil Consumption on Fatty Acid Metabolism, Transepidermal Water Loss and Skin Parameters in Elderly People. Archives of Gerontology and Geriatrics, 30, 139-150.
http://dx.doi.org/10.1016/S0167-4943(00)00046-7
[18] Zhang, M.J. and Spite, M. (2012) Resolvins: Anti-Inflammatory and Proresolving Mediators Derived from Omega-3 Polyunsaturated Fatty Acids. Annual Review of Nutrition, 32, 203-227.
http://dx.doi.org/10.1146/annurev-nutr-071811-150726
[19] Langley, R.G. and Ellis, C.N. (2004) Evaluating Psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician’s Global Assessment. Journal of the American Academy of Dermatology, 51, 563-569.
http://dx.doi.org/10.1016/j.jaad.2004.04.012
[20] Stalder, J.F. and Taieb, A. (1993) Severity Scoring of Atopic Dermatitis: The SCORAD Index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology, 186, 23-31.
http://dx.doi.org/10.1159/000247298
[21] Serup, J. (1995) EEMCO Guidance for Assessment of Dry Skin (Xerosis) and Ichthyosis. Skin Research and Technology, 1, 109-114.
http://dx.doi.org/10.1111/j.1600-0846.1995.tb00029.x
[22] Lewis-Jones, M.S., Finlay, A.Y. and Dykes, P.J. (2001) The Infants’ Dermatitis Quality of Life Index. British Journal of Dermatology, 144, 104-110.
[23] Finlay, A.Y. and Khan, G.K. (1994) Dermatology Life Quality Index (DLQI)—A Simple Practical Measure for Routine Clinical Use. Clinical and Experimental Dermatology, 19, 210-216.
http://dx.doi.org/10.1111/j.1365-2230.1994.tb01167.x
[24] Numerof, R.P. and Asadullah, K. (2006) Cytokine and Anti-Cytokine Therapies for Psoriasis and Atopic Dermatitis. BioDrugs, 20, 93-103.
http://dx.doi.org/10.2165/00063030-200620020-00004
[25] Wittmann, M., McGonagle, D. and Werfel, T. (2014) Cytokines as Therapeutic Targets in Skin Inflammation. Cytokine Growth Factor Reviews, 25, 443-451.
http://dx.doi.org/10.1016/j.cytogfr.2014.07.008

Journals Menu
Follow SCIRP
Contact us
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.